Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study.
OBJECTIVE: To determine the efficacy and safety of linagliptin in initial combination with metformin in patients with type 2 diabetes. METHODS: This 1-year randomised, double-blind study was an extension of a 6-month randomised controlled trial, in which ..... Read More